MYGNMyriad Genetics, Inc.

$454M

FY 2015 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$754M+4.2% YoY

Gross Profit

$597M79.1% margin

Operating Income

$167M22.1% margin

Net Income

$125M16.6% margin

EPS (Diluted)

$1.71

Cash Flow

Operating Cash Flow

$166M

Free Cash Flow

$161M

Stock-Based Comp.

$32M

Balance Sheet

Total Assets

$881M

Total Liabilities

$132M

Stockholders' Equity

$748M

Cash & Equivalents

$69M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$754M	$723M	+4.2%
Gross Profit	$597M	$576M	+3.6%
Operating Income	$167M	$134M	+24.3%
Net Income	$125M	$80M	+56.2%

MYGN FY 2015 Earnings — Myriad Genetics, Inc. Revenue & Financial Results | Market Cap Arena